In hepatitis C infection, KIR2DL3 homozygosity and HLA-C1 homozygosity are beneficial in both early eradication of infection and response to standard treatment (type I IFN + ribavirin administration) [73,74]. Here, KIR2DL3 is linked to hepatitis C virus infection.